The risk of NAFLD in the participants was measured using the Dallas Steatosis Index (DSI), based on the level of alanine aminotransferase, BMI, age, sex, levels of triglycerides and glucose, diabetes, hypertension, and ethnicity, ICD10 codes from hospital admissions for either NAFLD and/or NASH and the proton density fat fraction (PDFF) to describe the liver fat percentage. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.